Results 221 to 230 of about 4,732,777 (361)

Total Neoadjuvant Therapy Versus Conventional Neoadjuvant Therapy for Rectal Cancer: Cost Analysis in a Public Healthcare System. [PDF]

ANZ J Surg
Murshed I, Bedrikovetski S, Murshed I, Bunjo Z, Fitzsimmons T, Thomas M, Sammour T.   +6 more
europepmc   +1 more source

Quality‐adjusted life years in the presence and absence of organized mammographic screening using data from BreastScreen Norway

International Journal of Cancer, EarlyView.
What's New? Although mammographic screening can reduce breast cancer mortality and extend life, some studies have found a negative impact on net quality‐adjusted life years (QALYs). Here, the authors estimated net QALYs associated with biennial mammographic screening for women aged 50–69 years in Norway under various scenarios.
Rick Groeneweg, Nicolien T. van Ravesteyn, Lindy M. Kregting, Giske Ursin, Solveig Hofvind, Nataliia Moshina   +5 more
wiley   +1 more source

Neoadjuvant Therapy

Annals of Surgery, 1999
openaire   +2 more sources

Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials

, 2017
Maria Vittoria Dieci, Antonio Frassoldati, Daniele Generali, Giancarlo Bisagni, Federico Piacentini, Luigi Cavanna, Katia Cagossi, Francesco Maria Puglisi, Andrea Michelotti, Rossana Berardi, Giuseppe Luigi Banna, Aïcha Goubar, Guido Ficarra, Gaia Griguolo, Pierfranco Conté, Valentina Guarneri   +15 more
openalex   +2 more sources

Breast cancer incidence and survival by subtype, stage at diagnosis and socioeconomic deprivation among young women in the Community of Madrid, Spain

International Journal of Cancer, EarlyView.
What's New? Breast cancer comprises a heterogeneous group of diseases with differing features and survival outcomes. In particular, survival is affected by socioeconomic status, though age‐specific patterns remain unknown. Here, the authors examined differences in breast cancer incidence and survival specifically among young women in the Community of ...
Candela Pino‐Rosón, Sonia Ávila‐Arroyo, David Parra‐Blázquez, María J. Soto Zabalgogeazcoa, Daniel Moñino, Raquel López‐González, Clotilde Sevilla‐Hernández, Cristina González‐Blázquez, Miguel Martín, Nuria Aragonés   +9 more
wiley   +1 more source

Comparing efficacy of neoadjuvant therapy of triple-negative breast cancer: A Bayesian network meta-regression analysis. [PDF]

Medicine (Baltimore)
Jiang Y, Zeng J, Liu J, Deng W, Kahlert UD, Tang R, Xu M, Shi W, Wang Q.   +8 more
europepmc   +1 more source

Integrated PET/CT-perfusion in rectal cancer pre-and post neoadjuvant chemo- and radiation therapy: initial results

, 2011
Patrick Veit‐Haibach
openalex   +1 more source

Treatment landscape from first‐ to third‐line therapy and quality of life data of patients with pancreatic cancer from the prospective German PARAGON (Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer) registry (IKF‐PARAGON study)

International Journal of Cancer, EarlyView.
What's New? Pancreatic cancer often is diagnosed at advanced stages. As a result, treatment regimens frequently are aggressive, with substantial side effects that impact quality of life (QoL). This study examined the treatment landscape, from neoadjuvant therapy to palliative care, in the context of QoL among pancreatic cancer patients in Germany. Most
Thorsten O. Goetze, Salah‐Eddin Al‐Batran, Ruediger Liersch, Lars Scheuer, Thomas Goehler, Ulrich Kaiser, Claudio Denzlinger, Stephan Brandl, Daniel Pink, Jens Uhlig, Michael Maasberg, Maria Loose, Marina Schaaf, Disorn Sookthai, Bianca Zäpf, Claudia Pauligk, Timursah Habibzade, Ralf‐Dieter Hofheinz, Christine Koch, for the AIO Study Group   +19 more
wiley   +1 more source

The impact of circWWC3 on neoadjuvant therapy for triple-negative breast cancer and the construction of a nomogram for predicting pathological complete response after neoadjuvant therapy. [PDF]

Front Oncol
Wang H, Liu H, Gao S, Wang L, Bai Z, Zhang Y, Zhang P, Liu F, Geng C.   +8 more
europepmc   +1 more source

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.

Journal of Clinical Oncology, 2008
C. Liedtke, C. Mazouni, K. Hess, F. André, A. Tordai, J. Mejia, W. Symmans, A. González-Angulo, B. Hennessy, Marjorie C. Green, M. Cristofanilli, G. Hortobagyi, L. Pusztai   +12 more
semanticscholar   +1 more source